공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 암 분자진단 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년)

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028945
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,967,000 PDF (Single User License)
US $ 7,500 ₩ 8,950,000 PDF (Site License)
US $ 10,000 ₩ 11,934,000 PDF (Enterprise License)


세계의 암 분자진단 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년) Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 분자진단 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추이와 예측, 제품·기술·최종사용자·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 개요, 향후 전망 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 COVID-19의 영향

제5장 시장 규모 및 성장 예측

  • 시장 규모 추이와 예측
  • 성장 촉진요인
  • 성장 억제요인

제6장 시장 분석과 예측 : 각종 구분별

  • 제품별
    • 기기
    • 시약
    • 기타
  • 기술별
    • 중합효소 연쇄반응(PCR)
    • n-situ Hybridization (ISH)
    • 등온 핵산 증폭 기술(INNAT)
    • 칩 및 마이크로어레이
    • 시퀀싱
    • 질량분석
    • Transcription Mediated Amplification(TMA)
    • 기타
  • 최종사용자별
    • 병원
    • 진단센터
    • 학술/연구기관
    • 기타

제7장 시장 분석과 예측 : 지역/국가별

제8장 아시아태평양 시장 분석과 예측

  • 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 법규제, 기관&협회, 조세, 투자, 주요 기업
  • 시장 분석과 예측 : 제품별
  • 시장 분석과 예측 : 기술별

제9장 중국 시장 분석과 예측

제10장 인도 시장 분석과 예측

제11장 일본 시장 분석과 예측

제12장 호주 시장 분석과 예측

제13장 인도네시아 시장 분석과 예측

제14장 한국 시장 분석과 예측

제15장 서유럽 시장 분석과 예측

제16장 영국 시장 분석과 예측

제17장 독일 시장 분석과 예측

제18장 프랑스 시장 분석과 예측

제19장 동유럽 시장 분석과 예측

제20장 러시아 시장 분석과 예측

제21장 북미 시장 분석과 예측

제22장 미국 시장 분석과 예측

제23장 남미 시장 분석과 예측

제24장 브라질 시장 분석과 예측

제25장 중동 시장 분석과 예측

제26장 아프리카 시장 분석과 예측

제27장 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Abbott Diagnostics
    • Becton Dickinson
    • Cepheid
    • Danaher Corporation
    • Beckman Coulter

제28장 주요 인수합병(M&A)

제29장 향후 전망과 잠재성 분석

제30장 부록

LSH 21.10.06

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Molecular Diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.

Scope

Markets Covered:

1) By Product: Instruments; Reagents; Others

2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Others

3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Others

Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Trends And Strategies

4. Impact Of COVID-19 On Oncology Molecular Diagnostics

5. Oncology Molecular Diagnostics Market Size And Growth

  • 5.1. Global Oncology Molecular Diagnostics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oncology Molecular Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oncology Molecular Diagnostics Market Segmentation

  • 6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Instruments
  • Reagents
  • Others
  • 6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Others
  • 6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

7. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oncology Molecular Diagnostics Market

  • 8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oncology Molecular Diagnostics Market

  • 9.1. China Oncology Molecular Diagnostics Market Overview
  • 9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oncology Molecular Diagnostics Market

  • 10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oncology Molecular Diagnostics Market

  • 11.1. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oncology Molecular Diagnostics Market

  • 12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oncology Molecular Diagnostics Market

  • 13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oncology Molecular Diagnostics Market

  • 14.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oncology Molecular Diagnostics Market

  • 15.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • 15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oncology Molecular Diagnostics Market

  • 16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oncology Molecular Diagnostics Market

  • 17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oncology Molecular Diagnostics Market

  • 18.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oncology Molecular Diagnostics Market

  • 19.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • 19.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oncology Molecular Diagnostics Market

  • 20.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oncology Molecular Diagnostics Market

  • 21.1. North America Oncology Molecular Diagnostics Market Overview
  • 21.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oncology Molecular Diagnostics Market

  • 22.1. USA Oncology Molecular Diagnostics Market Overview
  • 22.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oncology Molecular Diagnostics Market

  • 23.1. South America Oncology Molecular Diagnostics Market Overview
  • 23.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oncology Molecular Diagnostics Market

  • 24.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oncology Molecular Diagnostics Market

  • 25.1. Middle East Oncology Molecular Diagnostics Market Overview
  • 25.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oncology Molecular Diagnostics Market

  • 26.1. Africa Oncology Molecular Diagnostics Market Overview
  • 26.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 27.1. Oncology Molecular Diagnostics Market Competitive Landscape
  • 27.2. Oncology Molecular Diagnostics Market Company Profiles
    • 27.2.1. Abbott Diagnostics
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Becton Dickinson
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Cepheid
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Danaher Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Beckman Coulter
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

29. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q